EXEL — Exelixis Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Exelixis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 30th	2023 December 29th	2025 January 3rd	2025 December 31st
Period Length:	52 W	52 W	52 W	53 W	52 W
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,467	1,308	995	1,111	1,059
Net Total Accounts Receivable
Net Total Receivables	283	215	237	265	287
Total Inventory
Prepaid Expenses
Total Current Assets	1,835	1,619	1,318	1,468	1,443
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	149	345	362	292	258
Net Goodwill
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,616	3,071	2,942	2,948	2,844
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	338	324	394	404	406
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	406	583	678	703	683
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2,211	2,488	2,264	2,244	2,161
Total Liabilities & Shareholders' Equity	2,616	3,071	2,942	2,948	2,844
Total Common Shares Outstanding